<DOC>
	<DOCNO>NCT01435161</DOCNO>
	<brief_summary>Different low blood pressure strategy different clinical efficacy . Blocking angiotensin II type 1 receptor ( Telmisartan ) reduce incidence episode atrial fibrillation hypertensive patient paroxysmal atrial fibrillation 24 month 30 % compare Nifedipine ( Adalat GITS ) . A total 160 subject include two study group . The Group 1 receive 80-160mg Telmisartan per day , remain patient receive Nifedipine ( Adalat GITS ) . Follow-up 24 month . The conventional 12-lead ECG recording twice week interval 24hrs holter monitor determine cardiac rhythm asymptomatic episode atrial fibrillation . The target Blood pressure 3 month less 130/80mmHg . Concomitant therapy B-blocker acethydrazide allow target blood pressure study .</brief_summary>
	<brief_title>Nifedipine v Telmisartan Prevention Atrial Fibrillation ( AF ) Recurrence Hypertensive Patients With AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Documented hypertensive patient paroxysmal atrial fibrillation : ECG documentation atrial fibrillation least one ECG record last 2 month prior randomization plus additional ECG record sinus rhythm least 12 hour mention ECG documentation . Patients hypertensive history least 5 year . Systolic pressure &gt; 140mmHg , &lt; 190mmHg , Diastolic pressure &gt; 85mmHg . &lt; 110mmHg . 40 &lt; Age &lt; 65 year Strong clinical evidence therapy AT II/ACE inhibitor 3 month screen Therapy antiarrhythmic agent class I class III within last month , therapy amiodarone within last 3 month Direct current ( DC ) cardioversion within last 3 month Symptomatic bradycardia Implanted pacemaker implant cardioverter/defibrillator antitachycardiac algorithm use Cardiac surgery cardiac catheter ablation within last 3 month Typical angina pectoris symptom rest exercise Known coronary artery disease indication intervention Valvular disease &gt; II degree Left ventricular ejection fraction &lt; 40 % Diastolic blood pressure &gt; 110mm Hg rest Symptomatic arterial hypotension Known renal artery stenosis Serum creatinine &gt; 1.8 mval/l Relevant hepatic pulmonary disorder Hyperthyroidism manifest clinically laboratory Known drug intolerance AT II inhibitor Females pregnant breast feeding Females childbearing potential use scientifically accept method contraception Participation clinical trial within last 30 day Drug addiction chronic alcohol abuse Legal incapacity , circumstance would prevent patient understanding aim , nature extent clinical study Evidence uncooperative attitude</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>paroxysmal atrial fibrillation , hypertension</keyword>
</DOC>